Ramírez-Prado D, Palazón-Bru A, Folgado-de-la Rosa D M, Carbonell-Torregrosa M Á, Martínez-Díaz A M, Gil-Guillén V F
Research Unit, Elda Hospital, Elda, Spain; Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain.
Int J Clin Pract. 2015 Apr;69(4):474-84. doi: 10.1111/ijcp.12563. Epub 2014 Sep 19.
Many authors have analysed premature mortality in cohorts of type 2 diabetic patients, but no analyses have assessed mortality in hospitalised diabetic patients.
To construct predictive models to estimate the likelihood of all-cause mortality and cardiovascular mortality in type 2 diabetic inpatients.
Cohort study with follow-up from 2010 to 2014.
We evaluated mortality in a randomly selected cohort of 112 type 2 diabetic inpatients at the Hospital of Elda (Spain) in 2010-2012.
all-cause mortality and cardiovascular mortality during the follow-up. Other variables: gender, age, depression, asthma/chronic obstructive pulmonary disease, hypertension, dyslipidemia, insulin, pills, smoking, walking, baseline blood glucose and creatinine. Predictive tables with risk groups were constructed to estimate the likelihood of all-cause mortality and cardiovascular mortality. Calculations were made of the area under the ROC curve (AUC).
During the follow-up, 52 inpatients died (46.4%, 95% CI, confidence interval: 37.2-55.7%), 22 because of cardiovascular causes (19.6%, 95% CI: 12.3-27.0%). The mean follow-up time was 2.7 ± 1.5 years. The AUC for the all-cause mortality model was 0.84 (95% CI: 0.77-0.92, p < 0.001). Associated parameters: pills, smoking, walking, gender, insulin and age. The AUC for the cardiovascular mortality model was 0.79 (95% CI: 0.67-0.91, p < 0.001). Associated parameters: age, pills, walking, smoking, depression and insulin.
This study provides tools to predict premature mortality in type 2 diabetic inpatients. However, before their general application they require joint validation by the internal medicine unit, emergency department, primary healthcare unit and endocrinology service to enable better prediction of the prognosis and more adequate decision-taking.
许多作者分析了2型糖尿病患者队列中的过早死亡率,但尚无分析评估住院糖尿病患者的死亡率。
构建预测模型,以估计2型糖尿病住院患者全因死亡率和心血管死亡率的可能性。
2010年至2014年的队列研究及随访。
我们评估了2010年至2012年在西班牙埃尔达医院随机选取的112例2型糖尿病住院患者的死亡率。
随访期间,52例住院患者死亡(46.4%,95%置信区间:37.2 - 55.7%),22例死于心血管原因(19.6%,95%置信区间:12.3 - 27.0%)。平均随访时间为2.7±1.5年。全因死亡率模型的曲线下面积(AUC)为0.84(95%置信区间:0.77 - 0.92,p<0.001)。相关参数:口服降糖药、吸烟、步行能力、性别、胰岛素使用情况和年龄。心血管死亡率模型的AUC为0.79(95%置信区间:0.67 - 0.91,p<0.001)。相关参数:年龄、口服降糖药、步行能力、吸烟、抑郁和胰岛素使用情况。
本研究提供了预测2型糖尿病住院患者过早死亡率的工具。然而,在广泛应用之前,它们需要内科、急诊科、基层医疗单位和内分泌科共同验证,以便更好地预测预后并做出更恰当的决策。